RecruitingNot applicableNCT04671771
A Study to Evaluate the Safety and Effectiveness of the InnAVasc Arteriovenous Graft for Hemodialysis Access in Patients With End-Stage Renal Disease
Studying Complication in hemodialysis
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- W.L.Gore & Associates
- Principal Investigator
- John Ross, MDMUSC Health Dialysis Access Institute
- Intervention
- InnAVasc Arteriovenous Graft (IG) surgical implant(device)
- Enrollment
- 133 target
- Eligibility
- 18-90 years · All sexes
- Timeline
- 2020 – 2029
Study locations (21)
- AKDHC Medical Research Services, LLC, Phoenix, Arizona, United States
- Sarasota Memorial Hospital, Sarasota, Florida, United States
- University of South Florida, Tampa, Florida, United States
- Piedmont Augusta, Augusta, Georgia, United States
- University of Louisville, Louisville, Kentucky, United States
- University of Maryland, Baltimore, Maryland, United States
- Brigham & Women's Hospital, Boston, Massachusetts, United States
- Rutgers, Newark, New Jersey, United States
- Mount Sinai Hospital, New York, New York, United States
- Northwell Health, New York, New York, United States
- Montefiore Medical Center, The Bronx, New York, United States
- Surgical Specialists of Charlotte, Charlotte, North Carolina, United States
- Duke University Medical Center, Durham, North Carolina, United States
- NC Heart and Vascular Research, LLC, Raleigh, North Carolina, United States
- WakeMed, Raleigh, North Carolina, United States
- +6 more locations on ClinicalTrials.gov
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT04671771 on ClinicalTrials.govOther trials for Complication in hemodialysis
Additional recruiting or active studies for the same condition.
- ACTIVE NOT RECRUITINGNCT07438925Copeptin Concentration Measured in Plasma Samples and Intradialytic Blood Pressure VariationCentral Hospital, Nancy, France
- RECRUITINGNANCT06341452Comparison of Individualized Sodium Management Versus Standard Treatment in HemodialysisFresenius Medical Care Deutschland GmbH
- RECRUITINGNANCT07512895The Effect of Progressive Muscle Relaxation Exercises on Depression and Fatigue in Patients Receiving Hemodialysis Treatment: A Randomized Controlled TrialIstanbul Aydın University
- RECRUITINGNANCT07269379Intradialytic Exercise With Blood Flow Restriction in Hemodialysis PatientsUniversity of Avignon
- ACTIVE NOT RECRUITINGNCT07412834Safely Disconnect From the Dialysis Machine in an Emergency SituationIstanbul University
- RECRUITINGPHASE1NCT07217886A Study of S-892216-PO in Participants With Renal Impairment and Matched ControlsShionogi
- RECRUITINGNANCT06978127Technology Assisted Collaborative Care Intervention to Improve Patient-centered Outcomes in Dialysis PatientsUniversity of Pittsburgh
- ACTIVE NOT RECRUITINGPHASE3NCT06901505To Evaluate the Efficacy of Three Times Weekly (TIW) Vadadustat Compared to Standard of Care ESA in Patients With Anemia of CKD Receiving In-Center HemodialysisAkebia Therapeutics